BMD adopted?,Substance common name,Substance CAS number,Assessment type,Exposure routes,Endpoint,Specific endpoint â€“ Adverse response,Type of the dose-response model,Power/Degree/Rho,BMR,Definition for BMD estimation,Reference point,Reference point value,Reference point unit,Uncertainty factor,Health based guidance values,HBGV value,HBGV unit,Study duration type,Study species,Study strains,Sex of test subjects,Study experimental model,Type of substance toxicity,Target organ,Type of data,Statistical paradigm,m(0),sigma"
"not specified,1,2-Dibromoethane,106-93-4,non-cancer,oral: gavage,Increase,Testicular atrophy; Liver peliosis; Adrenal cortical degeneration,not specified,not specified,not specified,not specified,not specified,not specified,mg/kg bw/day,3000,RfD,9 E-3,mg/kg bw/day,Chronic/long term toxicity,Rat,Osborne-Mendel,male and female,in vivo,Systemic toxicity; Reproductive Toxicity,Liver; Testicular; Adrenal,quantal,Frequentist,not specified,not specified